As cancer care professionals who experience the challenges of providing quality cancer care first-hand, VAHO members are well positioned to educate decision-makers on how coverage and reimbursement issues affect community oncology. State and federal legislation can have a significant impact on the financial viability of local cancer programs, which is why it's so important that our members make their voices heard.
In an effort to provide resources needed to effectively advocate on the issues that are important to them, our redesigned advocacy webpage features activity from the Centers for Medicare & Medicaid Services (CMS), national healthcare coverage through the Association of Community Cancer Centers (ACCC), local news articles and webinars, and more.
We want to hear from you! If there is a specific piece of legislation you want to know more about, an important resource we're missing, or if you want to get more involved, please contact us!
VAHO Joins Coalition Letter Urging Addition of the Cures 2.0 Concept Paper Title IV Provisions in the Next COVID-19 Relief Package
The Virginia Association of Hematologists and Oncologists (VAHO) joined in a coalition letter to congressional leadership urging that Congress include the 21st Century Cures 2.0 concept paper, recently released by Representatives Diana DeGette and Fred Upton in upcoming legislation to further address the COVID-19 public health crisis. Specifically the letter urges leadership to include policy to provide Medicaid coverage of the routine care costs of clinical trials participation for patients with life-threatening conditions in every state. This critical protection is championed by Representatives Ben Ray Luján and Gus Bilirakis in the Clinical Treatment Act (H.R. 913).
ACCC members were invited to join legal experts and their ACCC colleagues for a one-hour overview and discussion about the Centers for Medicare & Medicaid Services (CMS) final CY 2020 OPPS and PFS rules. The webinar covered key proposals the agency has finalized under the OPPS that will affect next year’s payments for 340B hospitals, excepted off-campus provider-based departments (PBDs), as well as updates to the administration's pricing transparency and drug pricing reform efforts. A recording of this webinar, presentation slides, and rule summaries are available to ACCC members.
ACCC members can access summaries of the final rules here. [Requires Login] Also available, a summary of selected provisions of the CY2020 Hospital Price Transparency Requirements for Hospitals to Make Standard Charges Public final rule. [Requires Login]
View On-Demand Webinar Replay (Requires Login)
On March 30, 2021, the Academy of Oncology Nurse & Patient Navigators (AONN+) Leadership Council released key reasons why cancer care teams should be protected and thoughtful investment strategies for cancer programs and practices to help remain strong as they recover from the pandemic. After closely reviewing the pandemic's impact on cancer care delivery in 2020, the Leadership Council devised key reasoning for protecting the cancer care team and service line:
The AONN+ Leadership Council is led by Christian Downs, executive director of the Association of Community Cancer Centers, with support from Linda Fleisher, principal investigator at Fox Chase Cancer Center, Lillie Shockney, co-founder of AONN+, Rani Khetarpal, vice president of Provider Partnerships at New Century Health, and Mandi Pratt-Chapman, associate center director of Patient-Centered Initiatives and Health Equity at George Washington Cancer Center.
For more information on the Leadership Councils' tips for a strong cancer care team post-pandemic, read the full announcement.
Centers for Medicare & Medicaid Services
Find Your Federal Representative
Office of the Governor
Virginia Health and Human Services Department